How much liver resection is too much?

American Journal of Surgery

Volumn 190, Issue 1, 2005, Pages 87-97

  Mullin, Emma J ^a   Metcalfe, Matthew S ^a   Maddern, Guy J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Functional reserve; Hepatic resection; Liver failure

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID; AMINOPHENAZONE; ANTICONVULSIVE AGENT; ARTERIAL KETONE BODY RATIO; ASIALOGLYCOPROTEIN RECEPTOR; CAFFEINE; DEETHYLLIDOCAINE; DIMETHADIONE; DRUG METABOLITE; GALACTOSE ELIMINATION CAPACITY; HIPPURIC ACID; INDOCYANINE GREEN; LIDOCAINE; TECHNETIUM 99M; TRIMETHADIONE; UNCLASSIFIED DRUG;

AMINO ACID CLEARANCE TEST; BREATH ANALYSIS; CAFFEINE CLEARANCE TEST; CHEMOEMBOLIZATION; CLASSIFICATION; FUNCTIONAL ASSESSMENT; HUMAN; LABORATORY TEST; LIVER BLOOD FLOW; LIVER CELL CARCINOMA; LIVER CLEARANCE; LIVER FAILURE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER METABOLISM; LIVER REGENERATION; LIVER RESECTION; LIVER WEIGHT; MEASUREMENT; MEDICAL DECISION MAKING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE;

EID: 20444498492     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.01.043     Document Type: Article

References (106)

1. W. Jarnagin, M. Gonen, Y. Fong Improvement in perioperative outcome after hepatic resection analysis of 1803 consecutive cases over the past decade Ann Surg 236 2002 397 407
2. G.D. Stewart, C.B. O'Suilleabhain, K.K. Madhavan The extent of resection influences outcome following hepatectomy for colorectal liver metastases Eur J Surg Oncol 30 2004 370 376
3. J. Bruix, A. Castells, J. Bosch Surgical resection of hepatocellular carcinoma in cirrhotic patients prognostic value of preoperative portal pressure Gastroenterology 111 1996 1018 1022
4. S.A. Little, W.R. Jarnagin, R.P. DeMatteo Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer J Gastrointest Surg 6 2002 88 94
5. Y. Ikeda, M. Shimada, H. Hasegawa Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection Hepatology 27 1998 1567 1571
6. T. Matsumata, A. Taketomi, N. Kawahara Morbidity and mortality after hepatic resection in the modern era Hepatogastroenterology 42 1995 456 460
7. T.I. Huo, J.C. Wu, W.Y. Lui Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment Am J Gastroenterol 99 2004 1479 1487
8. H. Lau, K. Man, S.T. Fan Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy Br J Surg 84 1997 1255 1259
9. M.S. Didolkar, J.L. Fitzpatrick, E.G. Elias Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure Surg Gynecol Obstet 169 1989 17 26
10. S. Kubo, S. Nishiguchi, T. Shuto Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma Jpn J Cancer Res 90 1999 162 170
11. E. Okamoto, A. Kyo, N. Yamanaka Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function Surgery 95 1984 586 592
12. K. Takenaka, T. Kanematsu, K. Fukuzawa Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented? World J Surg 14 1990 123 127
13. A. Nanashima, H. Yamaguchi, S. Shibasaki Measurement of serum hyaluronic acid level during the perioperative period of liver resection for evaluation of functional liver reserve J Gastroenterol Hepatol 16 2001 1158 1163
14. I. Albers, H. Hartmann, J. Bircher Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis Scand J Gastroenterol 24 1989 269 276
15. C.A. Redaelli, J. Dufour, M. Wagner Preoperative galactose elimination capacity predicts complications and survival after hepatic resection Ann Surg 235 2002 77 85
16. J.V. Sitzmann, P.S. Greene Perioperative predictors of morbidity following hepatic resection for neoplasm A multivariate analysis of a single surgeon experience with 105 patients Ann Surg 219 1994 13 17
17. N. Nagasue, H. Kohno, M. Tachibana Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis Ann Surg 229 1999 84 90
18. J.B. Dimick, J.A. Cowan Jr, J.A. Knol Hepatic resection in the United States indications, outcomes, and hospital procedural volumes from a nationally representative database Arch Surg 138 2003 185 191
19. N. Nagasue, H. Yukaya, Y. Ogawa Human liver regeneration after major hepatic resection A study of normal liver and livers with chronic hepatitis and cirrhosis Ann Surg 206 1987 30 39
20. S. Todo, A.J. Demetris, L. Makowka Primary nonfunction of hepatic allografts with preexisting fatty infiltration Transplantation 47 1989 903 905
21. Y. Soejima, M. Shimada, T. Suehiro Use of steatotic graft in living-donor liver transplantation Transplantation 76 2003 344 348
22. M. Selzner, H.A. Rudiger, D. Sindram Mechanisms of ischemic injury are different in the steatotic and normal rat liver Hepatology 32 2000 1280 1288
23. K.E. Behrns, G.G. Tsiotos, N.F. DeSouza Hepatic steatosis as a potential risk factor for major hepatic resection J Gastrointest Surg 2 1998 292 298
24. M.F. Chen, H.P. Tsai, L.B. Jeng Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers univariate and multivariate analysis World J Surg 27 2003 443 447
25. Y. Fong, R.L. Sun, W. Jarnagin An analysis of 412 cases of hepatocellular carcinoma at a Western center Ann Surg 229 1999 790 800
26. C.N. Yeh, M.F. Chen, W.C. Lee Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis univariate and multivariate analysis J Surg Oncol 81 2002 195 202
27. B. Philosophe, P.D. Greig, A.W. Hemming Surgical management of hepatocellular carcinoma resection or transplantation? J Gastrointest Surg 2 1998 21 27
28. H. Imamura, Y. Seyama, N. Kokudo One thousand fifty-six hepatectomies without mortality in 8 years Arch Surg 138 2003 1198 1206
29. G. Tanabe, M. Sakamoto, K. Akazawa Intraoperative risk factors associated with hepatic resection Br J Surg 82 1995 1262 1265
30. A.W. Hemming, S. Gallinger, P.D. Greig The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients J Gastrointest Surg 5 2001 316 321
31. S.M. Riordan, R. Williams Preoperative investigation and indication for operation in hepatocellular carcinoma J Hepatobiliary Pancreat Surg 5 1998 1 6
32. K. Chijiiwa, M. Watanabe, K. Nakano Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice Am J Surg 179 2000 161 166
33. S.T. Fan, E.C. Lai, C.M. Lo Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis Arch Surg 130 1995 198 203
34. A.W. Hemming, C.H. Scudamore, C.R. Shackleton Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients Am J Surg 163 1992 515 518
35. C.M. Lam, S.T. Fan, C.M. Lo Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test Br J Surg 86 1999 1012 1017
36. K. Kubota, M. Makuuchi, K. Kusaka Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors Hepatology 26 1997 1176 1181
37. M. Makuuchi, T. Kosuge, T. Takayama Surgery for small liver cancers Semin Surg Oncol 9 1993 298 304
38. S. Kawasaki, M. Makuuchi, S. Miyagawa Results of hepatic resection for hepatocellular carcinoma World J Surg 19 1995 31 34
39. M. Minagawa, M. Makuuchi, T. Takayama Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma Ann Surg 238 2003 703 710
40. S. Miyagawa, M. Makuuchi, S. Kawasaki Changes in serum amylase level following hepatic resection in chronic liver disease Arch Surg 129 1994 634 638
41. T. Suehiro, K. Sugimachi, T. Matsumata Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma Comparison with alpha-fetoprotein Cancer 73 1994 2464 2471
42. R. Mizumoto, Y. Kawarada, T. Noguchi Preoperative estimation of operative risk in liver surgery with special reference to functional reserve of the remnant liver following major hepatic resection Jpn J Surg 9 1979 343 349
43. K. Ozawa, H. Aoyama, K. Yasuda Metabolic abnormalities associated with postoperative organ failure A redox theory Arch Surg 118 1983 1245 1251
44. S.T. Fan, Q.S. Wang, C.M. Lo Evaluation of indocyanine green retention and aminopyrine breath tests in patients with malignant biliary obstruction Aust N Z J Surg 64 1994 759 762
45. O. Okochi, T. Kaneko, H. Sugimoto ICG pulse spectrophotometry for perioperative liver function in hepatectomy J Surg Res 103 2002 109 113
46. D. Clements, P. McMaster, E. Elias Indocyanine green clearance in acute rejection after liver transplantation Transplantation 46 1988 383 385
47. M. Oellerich, M. Burdelski, H.U. Lautz Assessment of pretransplant prognosis in patients with cirrhosis Transplantation 51 1991 801 806
48. K.N. Furuya, P.R. Durie, E.A. Roberts Glycine conjugation of para-aminobenzoic acid (PABA) a quantitative test of liver function Clin Biochem 28 1995 531 540
49. S. Lebel, Y. Nakamachi, A. Hemming Glycine conjugation of para-aminobenzoic acid (PABA) a pilot study of a novel prognostic test in acute liver failure in children J Pediatr Gastroenterol Nutr 36 2003 62 71
50. L.F. Duffy, B. Kerzner, L. Seeff Preliminary assessment of glycine conjugation of para-aminobenzoic acid as a quantitative test of liver function Clin Biochem 28 1995 527 530
51. H. Lau, K. Man, S.T. Fan Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy Br J Surg 84 1997 1255 1259
52. G.H. Clowes Jr, W.V. McDermott, L.F. Williams Amino acid clearance and prognosis in surgical patients with cirrhosis Surgery 96 1984 675 685
53. A. Armuzzi, M. Candelli, M.A. Zocco Review article breath testing for human liver function assessment Aliment Pharmacol Ther 16 2002 1977 1996
54. J. Galizzi, R.G. Long, B.H. Billing Assessment of the (14C) aminopyrine breath test in liver disease Gut 19 1978 40 45
55. C. Herold, R. Heinz, G. Niedobitek Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C Liver 21 2001 260 265
56. C. Merkel, A. Gatta, M. Zoli Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis Comparison with the Pugh score Dig Dis Sci 36 1991 1197 1203
57. R.A. Gill, M.W. Goodman, G.R. Golfus Aminopyrine breath test predicts surgical risk for patients with liver disease Ann Surg 198 1983 701 704
58. Y. Horsmans, D. Lejeune, A.P. Geubel Hepatic [14C] aminopyrine demethylation capacity after portocaval shunting Comparative study in patients with and without arterialization of portal vein Dig Dis Sci 38 1993 2177 2182
59. E. Tanaka, D.D. Breimer In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease J Clin Pharm Ther 22 1997 237 249
60. G.J. Park, P.H. Katelaris, D.B. Jones Validity of the C-caffeine breath test as a noninvasive, quantitative test of liver function Hepatology 38 2003 1227 1236
61. N.R. Scott, D. Stambuk, J. Chakraborty Caffeine clearance and biotransformation in patients with chronic liver disease Clin Sci 74 1988 377 384
62. R. Jover, F. Carnicer, J. Sanchez-Paya Salivary caffeine clearance predicts survival in patients with liver cirrhosis Am J Gastroenterol 92 1997 1905 1908
63. C. Herold, R. Heinz, M. Radespiel-Troger Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity Liver 21 2001 26 30
64. F. Salerno, G. Borroni, P. Moser Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato J Hepatol 25 1996 474 480
65. G. Marchesini, V. Bua, A. Brunori Galactose elimination capacity and liver volume in aging man Hepatology 8 1988 1079 1083
66. T. Kiuchi, K. Ozawa, Y. Yamamoto Changes in arterial ketone body ratio in the phase immediately after hepatectomy Prognostic implications Arch Surg 125 1990 655 659
67. M. Asano, K. Ozawa, T. Tobe Postoperative prognosis as related to blood ketone body ratios in hepatectomized patients Eur Surg Res 15 1983 302 311
68. K. Asonuma, S. Takaya, R. Selby The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation Transplantation 51 1991 164 171
69. K. Hanazaki, M. Wakabayashi, H. Sodeyama Arterial ketone body ratio does not correlate with ischemic changes during major hepatectomy Hepatogastroenterology 45 1998 145 149
70. P.R. Froomes, H. Ghabrial, D.J. Morgan The effect of oxygen supplementation on the arterial ketone body ratio in human cirrhosis Digestion 66 2002 257 261
71. T. Tsubono, K. Tsukada, K. Hatakeyama Hepatic functional reserve in patients with obstructive jaundice an assessment by the redox tolerance test Am J Surg 169 1995 300 303
72. K. Mori, K. Ozawa, Y. Yamamoto Response of hepatic mitochondrial redox state to oral glucose load Redox tolerance test as a new predictor of surgical risk in hepatectomy Ann Surg 211 1990 438 446
73. E. Tanaka, S. Inomata, H. Yasuhara The clinical importance of conventional and quantitative liver function tests in liver transplantation J Clin Pharm Ther 25 2000 411 419
74. G. Ercolani, G.L. Grazi, R. Calliva The lidocaine (MEGX) test as an index of hepatic function its clinical usefulness in liver surgery Surgery 127 2000 464 471
75. Y.S. Huang, J.H. Chiang, J.C. Wu Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma predictive value of the monoethylglycinexylidide test Am J Gastroenterol 97 2002 1223 1227
76. L. Fabris, R.M. Jemmolo, G. Toffolo The monoethylglycinexylidide test for grading of liver cirrhosis Aliment Pharmacol Ther 13 1999 67 75
77. M. Oellerich, V.W. Armstrong The MEGX test a tool for the real-time assessment of hepatic function Ther Drug Monit 23 2001 81 92
78. M. Oellerich, M. Burdelski, B. Ringe Functional state of the donor liver and early outcome of transplantation Transplant Proc 23 1991 1575 1578
79. R. Reding, P. Wallemacq, J. de Ville de Goyet The unreliability of the lidocaine/monoethylglycinexylidide test for assessment of liver donors Transplantation 56 1993 323 326
80. K. Karayalcin, D.F. Mirza, R.F. Harrison The role of dynamic and morphological studies in the assessment of potential liver donors Transplantation 57 1994 1323 1327
81. M. Abei, E. Tanaka, N. Tanaka Clinical significance of the trimethadione tolerance test in chronic hepatitis a useful indicator of hepatic drug metabolizing capacity J Gastroenterol 30 1995 478 484
82. H. Nakamura, E. Tanaka, M. Kaneko The clinical importance of the trimethadione tolerance test as a method for quantitative assessment of hepatic functional reserve in patients with biliary atresia J Clin Pharm Ther 26 2001 417 424
83. A. Ishikawa, K. Fukao, K. Tsuji Trimethadione tolerance tests for the assessment of feasible size of hepatic resection in patients with hepatocellular carcinoma J Gastroenterol Hepatol 8 1993 426 432
84. I. Hino, T. Tamai, K. Satoh Index for predicting post-operative residual liver function by pre-operative dynamic liver SPET Nucl Med Commun 18 1997 1040 1048
85. H. Fujioka, Y. Kawashita, Y. Kamohara Utility of technetium-99m-labeled- galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve J Clin Gastroenterol 28 1999 329 333
86. T. Sawamura, S. Kawasato, Y. Shiozaki Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats Gastroenterology 81 1981 527 533
87. Y. Yumoto, M. Umeda, K. Ohshima Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin Cancer Chemother Pharmacol 33 1994 S1 S6
88. M. Kudo, D.R. Vera, R.C. Stadalnik In vivo estimates of hepatic binding protein concentration correlation with classical indicators of hepatic functional reserve Am J Gastroenterol 85 1990 1142 1148
89. K. Kinoshita, M. Ukikusa, K. Iwaisako Preoperative assessment of hepatic function utility of a new convenient two-compartment model analysis using galactosyl human serum albumin scintigraphy J Gastroenterol Hepatol 18 2003 99 104
90. E. Kawamura, S. Shiomi, H. Ishizu Natural course of changes in hepatic functional reserve in patients with chronic liver diseases evaluated by scintigraphy with GSA Hepatol Res 27 2003 129 135
91. Y. Sugai, A. Komatani, T. Hosoya Response to percutaneous transhepatic portal embolization new proposed parameters by 99mTc-GSA SPECT and their usefulness in prognostic estimation after hepatectomy J Nucl Med 41 2000 421 425
92. A.H. Kwon, Y. Matsui, S.K. Ha-Kawa Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy comparison between hepatocyte volume and liver volume by computed tomography Am J Gastroenterol 96 2001 541 546
93. K. Satoh, Y. Yamamoto, Y. Nishiyama 99mTc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy Ann Nucl Med 17 2003 61 67
94. K. Shirabe, M. Shimada, T. Gion Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume J Am Coll Surg 188 1999 304 309
95. C. Yigitler, O. Farges, R. Kianmanesh The small remnant liver after major liver resection how common and how relevant? Liver Transpl 9 2003 S18 S25
96. M. Shoup, M. Gonen, M. D'Angelica Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection J Gastrointest Surg 7 2003 325 330
97. D. Azoulay, D. Castaing, J. Krissat Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver Ann Surg 232 2000 665 672
98. A.W. Hemming, A.I. Reed, R.J. Howard Preoperative portal vein embolization for extended hepatectomy Ann Surg 237 2003 686 693
99. D. Franco, L. Capussotti, C. Smadja Resection of hepatocellular carcinomas Results in 72 European patients with cirrhosis Gastroenterology 98 1990 733 738
100. N. Nagasue, H. Yukaya, Y. Ogawa Clinical experience with 118 hepatic resections for hepatocellular carcinoma Surgery 99 1986 694 701
101. T. Nagao, S. Inoue, S. Goto Hepatic resection for hepatocellular carcinoma Clinical features and long-term prognosis Ann Surg 205 1987 33 40
102. N. Yamanaka, E. Okamoto, K. Kuwata, N. Tanaka A multiple regression equation for prediction of posthepatectomy liver failure Ann Surg 200 1984 658 663
103. N. Yamanaka, E. Okamoto, T. Oriyama A prediction scoring system to select the surgical treatment of liver cancer Further refinement based on 10 years of use Ann Surg 219 1994 342 346
104. K. Ozawa, T. Ida, T. Yamada Significance of glucose tolerance as prognostic sign in hepatectomized patients Am J Surg 131 1976 541 546
105. G. Torzilli, M. Makuuchi, K. Inoue No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients is there a way? A prospective analysis of our approach Arch Surg 134 1999 984 992
106. C.A. Redaelli, M. Wagner, L. Krahenbuhl Liver surgery in the era of tissue-preserving resections early and late outcome in patients with primary and secondary hepatic tumors World J Surg 26 2002 1126 1132